This study investigates advanced pancreatic cancer. It is being conducted to evaluate the safety, tolerability, and efficacy of investigational medication alone or in combination with other treatments.
The study focuses on understanding how well the investigational medication works and how safe it is for patients with advanced pancreatic cancer.
- Who can participate: Adults aged 18 to 75 with advanced pancreatic cancer and specific health criteria can participate.
- Study details: Participants will receive investigational medication alone or with other treatments. A placebo may be used, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.